Exploring the potential benefits of vaccinia virus complement controlprotein in controlling complement activation in pathogenesis of the central nervous system diseases
Aging is a major risk factor for the development of diseases related to the central nervous system (CNS), such as Alzheimer's disease (AD) and age-related macular degeneration (AMD). In both cases, linkage studies and genome-wide association studies found strong links with complement regulatory genes and disease risk. In AD, both CLU and CR1 genes were implicated in the late-onset form of the disease. In AMD, polymorphisms in CFH, CFB and C2 were similarly implicated. The cost of caring for...[Show more]
|Collections||ANU Research Publications|
|01_Kotwal_Exploring_the_potential_2014.pdf||1.05 MB||Adobe PDF||Request a copy|
Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.